Exploiting Naturally Occurring Mutations to Engineer Next Generation T Cell Therapies 2022 Emerging Leader Award Jaehyuk Choi, MD, PhD, Northwestern University Read More
Molecular Mechanisms of Epigenetic Crosstalk between Histone Modifications and DNA Methylation in Cancer: New Avenues for Drug Development 2022 Emerging Leader Award Karim-Jean Armache, PhD, New York University Read More
Discovering the Mechanisms of Tumorigenesis by Driver Mutations Across Tissues ASPIRE Award (2022-2023) Nuria Lopez-Bigas, PhD, IRB Barcelona (Spain) Read More
Deciphering Clonal Competition Between Oncogenic Mutant and Normal Cells And its Effect on Cancer Initiation Damon Runyon - Mark Foundation Postdoctoral Fellow (2021-Present) Siqi Li, PhD, Fred Hutchinson Cancer Research Center Read More
The Role of Ribosomal Heterogeneity in T Cell Recognition of Tumor Cells ASPIRE Award (2021-2022) Pia Kvistborg, PhD and William Faller, PhD, Netherlands Cancer Institute (NKI) (The Netherlands) Read More
A Platform for Identifying Druggable Targets of Cancer Persisters to Mitigate Tumor Recurrence ASPIRE II Award, (2021-Present) Steven Altschuler, PhD; Lani Wu, PhD; Xiaoxiao Sun, PhD, University of California, San Francisco Read More
